Pharmacological characterization of LY335979: A potent cyclopropyldibenzosuberane modulator of P-glycoprotein
- 31 December 1997
- journal article
- Published by Elsevier in Advances in Enzyme Regulation
- Vol. 37, 335-347
- https://doi.org/10.1016/s0065-2571(96)00021-0
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- What have we learnt thus far from mice with disrupted P-glycoprotein genes?European Journal Of Cancer, 1996
- Methanodibenzosuberylpiperazines as potent multidrug resistance reversal agentsBioorganic & Medicinal Chemistry Letters, 1995
- Structure-activity relationship of verapamil analogs and reversal of multidrug resistanceBiochemical Pharmacology, 1995
- P-glycoprotein-mediated multidrug resistance in tumor cells: Biochemistry, clinical relevance and modulationMolecular Aspects of Medicine, 1995
- Clinical trials of modulation of multidrug resistance pharmacokinetic and pharmacodynamic considerationsCancer, 1993
- Pharmacologic circumvention of multidrug resistanceCytotechnology, 1993